Efficacy & Safety of Remo-Wax for Removal of Impacted Earwax

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Description

This is an open, single-arm multicentre study to confirm the efficacy and safety of a commercially available Remo-Wax ear drops containing allantoin for dissolving and removing impacted earwax. Subjects that qualify for enrollment and provide informed consent wil be treated with topical earwax softening product. ;

NCT number	NCT03802903
Study type	Interventional
Source	Orion Corporation, Orion Pharma
Contact
Status	Completed
Phase	N/A
Start date	March 12, 2019
Completion date	April 29, 2019

Status	Clinical Trial	Phase
Completed	`NCT04743817` - Feasibility Evaluation of OtoSet	N/A
Not yet recruiting	`NCT04094116` - Comparison of Effectiveness of Ear Syringing With or Without Pre-Ear Oil Application , Non-randomized Control Trial.	N/A
Completed	`NCT04653662` - Earol Madrid Study	N/A
Completed	`NCT02829294` - Evaluation of a Novel Product for the Removal of Impacted Human Cerumen (Earwax)	N/A

Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax — Remo-Wax

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms